Taking on the unique challenges of paediatric cancer
Article
Mon Jun 08 2026
9 min read
Fresh from being awarded one of the inaugural early-stage therapeutic programmes from C-Further, we caught up with Marco Purbhoo from MiNK Therapeutics to talk biotech’s role in paediatric oncology, promising targets and what can be done to attract private sector investment in the area.
The initiative brings together expertise across academia and industry, allowing us to move efficiently from promising biology to development of disease-relevant models and defined clinical candidate.
Marco Purbhoo
Head of Translational Medicine at MiNK Therapeutics